更多...
收起
The protein encoded by this gene is actually a preproprotein that is cleaved into four distinct mature peptides. One of these, glucagon, is a pancreatic hormone that counteracts the glucose-lowering action of insulin by stimulating glycogenolysis and gluconeogenesis. Glucagon is a ligand for a specific G-protein linked receptor whose signalling pathway controls cell proliferation. Two of the other peptides are secreted from gut endocrine cells and promote nutrient absorption through distinct mechanisms. Finally, the fourth peptide is similar to glicentin, an active enteroglucagon. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):]  由该基因编码的蛋白质实际上是被切割成四个不同的成熟肽一个前原。其中之一,胰高血糖素,是胰腺激素,通过刺激糖原分解和糖原异生抵消胰岛素的降血糖作用。胰高血糖素为特定的G蛋白偶联受体,其信号通路控制细胞增殖的配体。其他肽两个来自肠内分泌细胞分泌,并通过不同的机制促进营养吸收。最后,第四肽类似于肠高血糖素,活性enteroglucagon。 [由RefSeq的,2008年7月提供]
GCG基因(以及对应的蛋白质)的细胞分布位置:
GCG基因的本体(GO)信息:
疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
Diabetes Mellitus, Non-Insulin-Dependent | 0.154364835 | 89 | 2 | BeFree_CTD_human_GAD |
Obesity | 0.129153079 | 27 | 1 | BeFree_CTD_human_GAD |
Hyperglycemia | 0.126786047 | 27 | 3 | BeFree_CTD_human |
Hyperinsulinism | 0.121628651 | 7 | 0 | BeFree_CTD_human |
Colitis | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Hypertensive disease | 0.120271442 | 2 | 0 | BeFree_CTD_human |
Catalepsy | 0.12 | 1 | 0 | CTD_human |
Colonic Neoplasms | 0.12 | 1 | 0 | CTD_human |
Comatose | 0.12 | 1 | 0 | CTD_human |
Constipation | 0.12 | 1 | 0 | CTD_human |
Heart Diseases | 0.12 | 1 | 0 | CTD_human |
Heart failure | 0.12 | 1 | 0 | CTD_human |
Hyperlipidemia | 0.12 | 1 | 0 | CTD_human |
Hypotension | 0.12 | 2 | 0 | CTD_human |
Hypothermia, natural | 0.12 | 1 | 0 | CTD_human |
Spasm | 0.12 | 1 | 0 | CTD_human |
Stomach Diseases | 0.12 | 1 | 0 | CTD_human |
Tachycardia | 0.12 | 1 | 0 | CTD_human |
Sinus Tachycardia | 0.12 | 1 | 0 | CTD_human |
Vascular Diseases | 0.12 | 1 | 0 | CTD_human |
Hyperactive behavior | 0.12 | 1 | 0 | CTD_human |
Bradycardia | 0.12 | 5 | 0 | CTD_human |
Aberrant Crypt Foci | 0.12 | 1 | 0 | CTD_human |
Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
Diabetes Mellitus | 0.015667684 | 50 | 2 | BeFree_GAD |
Diabetes | 0.011129117 | 41 | 2 | BeFree |
Impaired glucose tolerance | 0.006263026 | 5 | 0 | BeFree_LHGDN |
Hypoglycemia | 0.005428837 | 20 | 0 | BeFree |
Diabetes Mellitus, Insulin-Dependent | 0.003257302 | 12 | 0 | BeFree |
Irritable Bowel Syndrome | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Neoplasm Metastasis | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Short Bowel Syndrome | 0.002995792 | 2 | 0 | BeFree_LHGDN |
Muscular Dystrophy, Oculopharyngeal | 0.002985861 | 11 | 0 | BeFree |
Atherosclerosis | 0.002909916 | 3 | 0 | BeFree_GAD |
Adenocarcinoma | 0.00272435 | 1 | 0 | LHGDN |
Anorexia Nervosa | 0.00272435 | 1 | 0 | LHGDN |
Food Allergy | 0.00272435 | 1 | 0 | LHGDN |
Myocardial Infarction | 0.00272435 | 1 | 0 | LHGDN |
Renal Insufficiency | 0.00272435 | 1 | 0 | LHGDN |
Glucagonoma | 0.001085767 | 4 | 0 | BeFree |
insulinoma | 0.001085767 | 4 | 0 | BeFree |
Malignant neoplasm of breast | 0.000814326 | 3 | 0 | BeFree |
Pancreatitis, Chronic | 0.000814326 | 3 | 0 | BeFree |
Pancreatic carcinoma | 0.000814326 | 3 | 0 | BeFree |
Malignant neoplasm of pancreas | 0.000814326 | 3 | 0 | BeFree |
Metabolic Syndrome X | 0.000814326 | 3 | 0 | BeFree |
Breast Carcinoma | 0.000814326 | 3 | 0 | BeFree |
Arteriosclerosis | 0.000542884 | 2 | 0 | BeFree |
Malignant tumor of colon | 0.000542884 | 2 | 0 | BeFree |
Cardiovascular Diseases | 0.000542884 | 2 | 0 | BeFree |
Pheochromocytoma | 0.000542884 | 2 | 0 | BeFree |
Pituitary Diseases | 0.000542884 | 2 | 0 | BeFree |
Acute myocardial infarction | 0.000542884 | 2 | 0 | BeFree |
Neuroendocrine Tumors | 0.000542884 | 2 | 0 | BeFree |
Dyslipidemias | 0.000542884 | 2 | 0 | BeFree |
Maturity onset diabetes mellitus in young | 0.000542884 | 2 | 0 | BeFree |
Malignant neoplasm of prostate | 0.000542884 | 2 | 0 | BeFree |
Non-alcoholic Fatty Liver Disease | 0.000542884 | 2 | 0 | BeFree |
Oculopharyngodistal Myopathy | 0.000542884 | 2 | 0 | BeFree |
Coronary Artery Disease | 0.000542884 | 2 | 0 | BeFree |
Azoospermia | 0.000271442 | 1 | 0 | BeFree |
Malignant neoplasm of larynx | 0.000271442 | 1 | 0 | BeFree |
Cardiomyopathy, Dilated | 0.000271442 | 1 | 0 | BeFree |
Coronary Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
Coronary heart disease | 0.000271442 | 1 | 0 | BeFree |
Crohn Disease | 0.000271442 | 1 | 0 | BeFree |
Diabetic Nephropathy | 0.000271442 | 1 | 0 | BeFree |
Diarrhea | 0.000271442 | 1 | 0 | BeFree |
Fibrosarcoma | 0.000271442 | 1 | 0 | BeFree |
Von Hippel-Lindau Syndrome | 0.000271442 | 1 | 0 | BeFree |
Intestinal Diseases | 0.000271442 | 1 | 0 | BeFree |
Intestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
Liver Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
Liver diseases | 0.000271442 | 1 | 0 | BeFree |
Multiple Endocrine Neoplasia Type 1 | 0.000271442 | 1 | 0 | BeFree |
Multiple Endocrine Neoplasia Type 2a | 0.000271442 | 1 | 0 | BeFree |
Meningioma | 0.000271442 | 1 | 0 | BeFree |
Metabolic Diseases | 0.000271442 | 1 | 0 | BeFree |
Spinal Muscular Atrophy | 0.000271442 | 1 | 0 | BeFree |
Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Nodule | 0.000271442 | 1 | 0 | BeFree |
polyps | 0.000271442 | 1 | 0 | BeFree |
Psoriasis | 0.000271442 | 1 | 0 | BeFree |
Subacute Sclerosing Panencephalitis | 0.000271442 | 1 | 0 | BeFree |
Substance Dependence | 0.000271442 | 1 | 0 | BeFree |
Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
Gestational Diabetes | 0.000271442 | 1 | 0 | BeFree |
Malnutrition | 0.000271442 | 1 | 1 | BeFree |
Diabetes, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
Gastrointestinal Stromal Tumors | 0.000271442 | 1 | 0 | BeFree |
Fasting Hypoglycemia | 0.000271442 | 1 | 0 | BeFree |
Reactive hypoglycemia | 0.000271442 | 1 | 0 | BeFree |
Benign Meningioma | 0.000271442 | 1 | 0 | BeFree |
Chronic ulcer | 0.000271442 | 1 | 0 | BeFree |
Corneal dystrophy, Lattice type 3 | 0.000271442 | 1 | 0 | BeFree |
Diabetes mellitus autosomal dominant type II (disorder) | 0.000271442 | 1 | 0 | BeFree |
Diabetes-deafness syndrome maternally transmitted (disorder) | 0.000271442 | 1 | 0 | BeFree |
Neurodegenerative Disorders | 0.000271442 | 1 | 0 | BeFree |
Prostate carcinoma | 0.000271442 | 1 | 0 | BeFree |
Lung Diseases, Obstructive | 0.000271442 | 1 | 0 | BeFree |
Colon Carcinoma | 0.000271442 | 1 | 0 | BeFree |
Central neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
Microalbuminuria | 0.000271442 | 1 | 0 | BeFree |
Taste sweet | 0.000271442 | 1 | 0 | BeFree |
Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
Sarcoma | 0.000271442 | 1 | 0 | BeFree |
Liver regeneration disorder | 0.000271442 | 1 | 0 | BeFree |
Pancreatic Ductal Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
Drug Dependence | 0.000271442 | 1 | 0 | BeFree |
Cirrhosis | 0.000271442 | 1 | 0 | BeFree |
BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY | 0.000271442 | 1 | 0 | BeFree |
Liver carcinoma | 0.000271442 | 1 | 0 | BeFree |
Nonalcoholic Steatohepatitis | 0.000271442 | 1 | 0 | BeFree |
Insulin resistance syndrome | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。